Daniel has nearly 15 years of experience in healthcare investing. Prior to joining Oyster Point Pharma, Daniel held positions of increasing responsibility in equity investing and fund management at Goldman Sachs Asset Management. Most recently he was a Managing Director and Portfolio Manager at Goldman Sachs, where he was a healthcare equity investor for various fund strategies.
As a healthcare investor, Daniel focused on biotechnology, pharmaceutical, medical device, and healthcare services companies and invested in a range of therapeutic categories, including ophthalmology. Daniel received an Executive MBA. from Columbia University and a BA in economics from the University of Richmond.